secwatch.observer — SEC 8-K summary
======================================

Issuer:     CARDINAL HEALTH INC (CAH)
CIK:        0000721371
Form:       8-K
Filed at:   2026-02-05T23:59:59+00:00
Accession:  0000721371-26-000004
Event type: earnings
Sentiment:  positive
Materiality: 0.85
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cardinal Health Q2 revenue $65.6B (+19%), non-GAAP EPS $2.63 (+36%), raises FY26 EPS outlook to $10.15-$10.35
--------------------------------------------------------------------------------

- Revenue $65.6B (+19% YoY); GAAP diluted EPS $1.97 (+19%); non-GAAP diluted EPS $2.63 (+36%).
- Pharma & Specialty profit $687M (+29%); Global Medical Products profit $37M (+106%); Other profit $179M (+52%).
- FY2026 non-GAAP EPS guidance raised to $10.15-$10.35, representing 23%-26% growth.
- Year-to-date share repurchases of $750M completed; reached targeted leverage range.
- Acquired Solaris Health (urology MSO, >750 providers) on Nov 3; introduced ContinuCare Pathway program.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/721371/000072137126000004/0000721371-26-000004-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/721371/000072137126000004/cah-20260205.htm
  HTML page:      https://secwatch.observer/filing/0000721371-26-000004

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer